Autologous Hematopoietic Stem Cell Transplantation
Mostrando 1-12 de 44 artigos, teses e dissertações.
-
1. Generation of hematopoietic stem/progenitor cells with sickle cell mutation from induced pluripotent stem cell in serum-free system
ABSTRACT Introduction Sickle cell disease (SCD) is a monogenic disease and it is estimated that 300,000 infants are born annually with it. Most treatments available are only palliative, whereas the allogeneic hematopoietic stem cell transplantation offers the only potential cure for SCD. Objective Generation of human autologous cells, when coupled with ind
Hematol., Transfus. Cell Ther.. Publicado em: 2021-06
-
2. The impact of multiple myeloma induction therapy on hematopoietic stem cell mobilization and collection: 25-year experience
ABSTRACT While first-line induction therapy for patients with multiple myeloma has changed over the years, autologous hematopoietic stem cell transplantation still plays a significant role, improving both depth of response and progression-free survival of myeloma patients. Our 25-year experience in mobilizing hematopoietic stem and progenitor cells for 472 t
Hematol., Transfus. Cell Ther.. Publicado em: 25/11/2019
-
3. Hand hygiene: knowledge and skill of caregivers in the hematopoietic stem cell transplantation
RESUMO Objetivo: identificar o conhecimento e habilidade de cuidadores sobre higiene das mãos no transplante de células-tronco hematopoéticas. Método: estudo transversal prospectivo. Utilizou-se questionário para identificar o conhecimento e foi observada a execução da técnica de higienização. Os dados foram coletados em duas unidades (transplant
Rev. Bras. Enferm.. Publicado em: 21/10/2019
-
4. Nine-year follow up after hematopoietic stem cell transplantation in five multiple sclerosis patients
RESUMO A esclerose múltipla é uma doença imunomediada do sistema nervoso central. Seu tratamento tem sido focado no controle da inflamação o mais cedo possível para evitar incapacidade. O transplante autólogo de células tronco hematopoiéticas (TACTH) vem sendo usado para tratar esclerose múltipla desde 1996, e recentes resultados foram decisivos a
Arq. Neuro-Psiquiatr.. Publicado em: 05/09/2019
-
5. Virtual learning object in hematopoietic stem cell transplantation for autoimmune diseases
RESUMO Objetivo: descrever o desenvolvimento de um objeto virtual de aprendizagem para disponibilização de informações sobre transplante autólogo de células-tronco hematopoéticas para doenças autoimunes. Métodos: estudo metodológico de desenvolvimento de um website, empregando o modelo de design instrucional que envolve Análise, Design, Desenvol
Rev. Bras. Enferm.. Publicado em: 19/08/2019
-
6. First - line, non - cryopreserved autologous stem cell transplant for poor - risk germ - cell tumors: Experience in a developing country
ABSTRACT Purpose: The current first - line treatment for non - seminomatous germ cell tumor (NSGCT) consists of four cycles of cisplatin, etoposide, and bleomycin (BEP), which results in 5 - year overall survival < 60% in patients with poor - risk features. Autologous hematopoietic stem cell transplantation (auto - HSCT) as a method for overcoming high toxi
Int. braz j urol.. Publicado em: 2019-01
-
7. Bloodstream infection in hematopoietic stem cell transplantation outpatients: risk factors for hospitalization and death
ABSTRACT We described 235 bloodstream infection (BSI) episodes in 146 hematopoietic stem cell transplantation (HSCT) outpatients and evaluated risk factors for hospitalization and death. Records of outpatients presenting with positive blood cultures over a 5-year period (January 2005 to December 2008) were reviewed. Variables with p< 0.1 in bivariate analysi
Rev. Inst. Med. trop. S. Paulo. Publicado em: 20/12/2018
-
8. Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis
Abstract Background: Secondary myeloid neoplasms comprise a group of diseases arising after chemotherapy, radiation, immunosuppressive therapy or from aplastic anemia. Few studies have addressed prognostic factors in these neoplasms. Method: Forty-two patients diagnosed from 1987 to 2008 with secondary myeloid neoplasms were retrospectively evaluated conce
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-03
-
9. Oral plasmablastic lymphoma as the first manifestation of AIDS
Abstract Plasmablastic lymphoma is a non-Hodgkin lymphoma characterized by its plasmacytic differentiation and predilection for the oral cavity. It is among the lymphomas most commonly associated with AIDS. This report details a case of a HIV-positive patient with a 1-month history of an exophytic mass in the gingival area of the upper left quadrant. The dia
An. Bras. Dermatol.. Publicado em: 2017
-
10. Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-12
-
11. Herpes zoster after autologous hematopoietic stem cell transplantation
ABSTRACT Background: The autologous hematopoietic stem cell transplantation procedure involves immunosuppression of the patient. Thus, the patient has an elevated risk for several diseases, such as infections with the varicella-zoster virus. Prevention protocols have been proposed based on the use of acyclovir from the first day of conditioning, and maintai
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-12
-
12. Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
ABSTRACT Introduction: Allogeneic hematopoietic stem cell transplantation offers the opportunity for extended survival in patients with Hodgkin's and non-Hodgkin lymphomas who relapsed after, or were deemed ineligible for, autologous transplantation. This study reports the cumulative experience of a single center over the past 14 years aiming to define the
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-12